News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
David Steensma: I learned how to talk to patients with leukemia largely from Mark
Photo of David Steensma and Mark Litzow from LinkedIn
Jan 1, 2024, 18:10

David Steensma: I learned how to talk to patients with leukemia largely from Mark

David Steensma, Chief Medical Officer at

“A true gentleman and scholar, and compassionate clinician – I learned how to talk to patients with leukemia largely from Mark. Enjoy your well deserved retirement!”

Quoting Mrinal Patnaik‘s post:

“Thank you Mark Litzow for everything you have done for patients with Leukemia. Your contributions to ALL Mayo Clinic Comprehensive Cancer Center ECOG-ACRIN Cancer Research Group and ASH will be forever appreciated. All the very best on your retirement.”

Source: David Steensma/X and Mrinal Patnaik/X

 

ASH cancer David Steensma ECOG-ACRIN Mark Litzow Mrinal Patnaik OncoDaily Oncology
Special Coverage
Insight
Jan 20, 2025, 12:28
Myeloma Paper of the Day, January 20th, suggested by Robert Orlowski
Blog
Jan 20, 2025, 12:26
The first seminar of 2025 NCI Rising Scholars: Cancer Research Seminar Series
Blog
Jan 20, 2025, 12:16
Rita A. Sakr: Honored to present dear breast cancer survivors at SABCS24
Blog
Jan 20, 2025, 12:11
Catharine Young: Real progress doesn’t happen in isolation
Blog
Jan 20, 2025, 11:28
Fernanda Rivera's Journey as the first Mexican RadOnc Resident to receive the ASCO IDEA Award
Blog
Jan 20, 2025, 04:32
Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma
Blog
Jan 20, 2025, 04:29
Katsuaki Maehara: Lung EGFR mutations catalog
Opinion
Jan 20, 2025, 04:25
Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities
Blog
Jan 20, 2025, 04:21
Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family
Insight
Jan 20, 2025, 04:14
Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra
Insight
Jan 20, 2025, 04:00
FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer
Career
Jan 20, 2025, 03:10
Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research